Meso BioMatrix® Surgical Mesh for soft tissue repair – European Union
Product Features and Benefits
|Preservation of native structure||
|Retention of bioactive components||
|Designed with the surgeon in mind||
Indications for Use
"The Meso BioMatrix™ implant is intended for surgical implantation in the face, oronasal cavity, neck or breast in order to: repair or replace congenital, surgical or oncologic soft tissue defects to prevent deformity or defect recurrence; improve the cosmesis from augmentation or soft tissue reconstruction procedures; and provide structural support to weakened soft tissues to prevent deformity or defect recurrence following surgery, injury or disease."
Proven in-vitro* biologic activity
DSM invests in comprehensive analysis of our extracellular matrices to validate the gentle selectivity of the OPTRIX process. In vitro studies demonstrate:
- More rapid cell infiltration compared to dermis xenograft products2
- Greater retention of TGF-B and VEGF relative to incumbent commercial products2
- DSM, Data on File. In-vitro results are not necessarily indicative of clinical performance.
- BioMaterials. 2010 Sep;31(27):6934-40.
*In vitro data may not be indicative of clinical results.
Meso BioMatrix® and OPTRIX™ are trademarks of DSM.